BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12227182)

  • 1. [Regulation of retroviral replication and pathogenesis by host factors].
    Miyazawa M
    Uirusu; 2002 Jun; 52(1):69-76. PubMed ID: 12227182
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential host range expansion of the retroviruses.
    Spector DH
    Dev Biol Stand; 1992; 76():153-64. PubMed ID: 1335930
    [No Abstract]   [Full Text] [Related]  

  • 3. Endogenous retroviruses and the evolution of resistance to retroviral infection.
    Best S; Le Tissier PR; Stoye JP
    Trends Microbiol; 1997 Aug; 5(8):313-8. PubMed ID: 9263409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of retroviral infection in humanized mice.
    Marsden MD; Zack JA
    Virology; 2015 May; 479-480():297-309. PubMed ID: 25680625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host genetic factors that control immune responses to retrovirus infections.
    Miyazawa M; Tsuji-Kawahara S; Kanari Y
    Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host restriction factors in retroviral infection: promises in virus-host interaction.
    Zheng YH; Jeang KT; Tokunaga K
    Retrovirology; 2012 Dec; 9():112. PubMed ID: 23254112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular trafficking of retroviral genomes during the early phase of infection: viral exploitation of cellular pathways.
    Goff SP
    J Gene Med; 2001; 3(6):517-28. PubMed ID: 11778899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroviral proteins that interact with the host cell cytoskeleton.
    Naghavi MH; Goff SP
    Curr Opin Immunol; 2007 Aug; 19(4):402-7. PubMed ID: 17707624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-entry restriction of retroviral infections.
    Towers GJ; Goff SP
    AIDS Rev; 2003; 5(3):156-64. PubMed ID: 14598564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restriction of feline retroviruses: lessons from cat APOBEC3 cytidine deaminases and TRIM5alpha proteins.
    Münk C; Hechler T; Chareza S; Löchelt M
    Vet Immunol Immunopathol; 2010 Mar; 134(1-2):14-24. PubMed ID: 19896724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral infections: impact on chemokines and chemokine receptors.
    Woodland DL
    Viral Immunol; 2011 Dec; 24(6):427-8. PubMed ID: 22149970
    [No Abstract]   [Full Text] [Related]  

  • 12. [Molecular dialogue between human retroviruses and host cells].
    Devaux CA
    J Soc Biol; 1999; 193(3):317-24. PubMed ID: 10542964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host factors involved in resistance to retroviral infection.
    Takeuchi H; Matano T
    Microbiol Immunol; 2008 Jun; 52(6):318-25. PubMed ID: 18577167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diversity of retroviral diseases of the immune system.
    O'Neill HC
    Immunol Cell Biol; 1992 Jun; 70 ( Pt 3)():193-9. PubMed ID: 1333443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte subsets and abnormalities in retrovirally infected mice.
    Popp DM
    Crit Rev Immunol; 1990; 10(2):73-112. PubMed ID: 1963783
    [No Abstract]   [Full Text] [Related]  

  • 16. Tracing complement-retroviral interactions from mucosal surfaces to the lymphatic tissue.
    Banki Z; Soederholm A; Mullauer B; Dierich MP; Stoiber H
    Front Biosci; 2007 Jan; 12():2096-106. PubMed ID: 17127447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroviral infection of non-dividing cells: old and new perspectives.
    Yamashita M; Emerman M
    Virology; 2006 Jan; 344(1):88-93. PubMed ID: 16364740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What's the host and what's the microbe? The Marjory Stephenson Prize Lecture 2015.
    Weiss RA
    J Gen Virol; 2015 Sep; 96(9):2501-2510. PubMed ID: 26296666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyinosinic-polycytidylic acid treatment of Friend retrovirus-infected mice improves functional properties of virus-specific T cells and prevents virus-induced disease.
    Gibbert K; Dietze KK; Zelinskyy G; Lang KS; Barchet W; Kirschning CJ; Dittmer U
    J Immunol; 2010 Nov; 185(10):6179-89. PubMed ID: 20943997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poxviral/retroviral chimeric vectors allow cytoplasmic production of transducing defective retroviral particles.
    Holzer GW; Mayrhofer JA; Gritschenberger W; Dorner F; Falkner FG
    Virology; 1999 Jan; 253(1):107-14. PubMed ID: 9887323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.